Search

Your search keyword '"Kuijpers T"' showing total 818 results

Search Constraints

Start Over You searched for: Author "Kuijpers T" Remove constraint Author: "Kuijpers T"
818 results on '"Kuijpers T"'

Search Results

1. Acute Rheumatic Heart Disease

2. Kawasaki Disease

6. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

10. Evidence-based richtlijnen

13. Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections

16. POS0134 LEARNING FROM LONGITUDINAL DATA IN CHILDHOOD ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: WHICH BIOMARKERS HAVE PREDICTIVE VALUE FOR ENDOTHELIAL INVOLVEMENT?

17. POS0100 TARGETING NF-ΚB SIGNALLING IN B LINEAGE CELLS AS A POTENTIAL NOVEL TREATMENT STRATEGY FOR ANCA-ASSOCIATED VASCULITIS

20. Relationship between molecular pathogen detection and clinical disease in febrile children across Europe: a multicentre, prospective observational study

21. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases

22. Diagnosis of childhood febrile illness using a multi-class blood RNA molecular signature.

23. Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature.

24. Dysregulated endothelial cell markers in systemic lupus erythematosus:a systematic review and meta-analysis

25. Plan van aanpak monitor Mondgezondheid

26. Beoordelen en graderen van wetenschappelijk bewijs

27. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

31. Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study

32. Additional file 2 of Dysregulated endothelial cell markers in systemic lupus erythematosus: a systematic review and meta-analysis

37. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

38. Management of drug interactions with direct‐acting antivirals in Dutch HIV/hepatitis C virus‐coinfected patients: adequate but not perfect

40. Voortgangsrapportage Nationaal Preventieakkoord 2021

43. PB1938: 4WHIM: EVALUATING MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH WHIM SYNDROME VIA A GLOBAL PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION

44. OP0178 COVID-19 BREAKTHROUGH INFECTIONS IN VACCINATED PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES AND CONTROLS – DATA FROM TWO PROSPECTIVE COHORT STUDIES

45. POS1256 RISK FACTORS FOR SHORT-TERM ADVERSE EVENT IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES

46. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

47. A highly virulent variant of HIV-1 circulating in the Netherlands

48. Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study

49. Availability and use of rapid diagnostic tests for the management of acute childhood infections in Europe: A cross-sectional survey of paediatricians

Catalog

Books, media, physical & digital resources